JPMorgan Chase & Co. (JPMUS19)
Thailand Exchange · Thailand · prices in THB · close of 22 Oct 2026
Key indicators
| Last close | THB 22.50 |
|---|---|
| 52-week range | 18.00 – 24.40 |
| Return, 1 month / 3 months | −3.4% / −3.0% |
| Return, 1 year / 3 years | +16.7% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 23.2% |
| Worst drawdown (1 year) | -13.9% |
| Average daily value traded | 0.13M THB |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
JPMorgan Chase & Co. is a financial services firm based in New York that serves individuals, businesses and institutions. It provides consumer banking such as deposit accounts, credit cards and mortgages, along with commercial and investment banking services including lending, capital raising and advisory work. Its asset and wealth management arm offers investment products and portfolio services. The company also operates payment and treasury services for corporate clients across many countries.
JPMorgan Chase & Co. trades under the code JPMUS19 on the Thailand Exchange in Thailand, with its price quoted in Thai baht (THB). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
JPMorgan Chase & Co. (JPMUS19) trades on the Thailand Exchange in Thailand. It last closed at THB 22.50 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 459 of 1,349 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.7% and over the last three months it fell 3.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Thailand Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.4% | ||
| From 52-week high | -7.8% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.0% | ||
| 6-month return | 11.7% | ||
| 12-month return, skipping the last month | 20.8% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.9% | ||
| Liquidity | 17 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.13M THB | ||
| Zero-volume days | 5.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.9% |
|---|---|
| 1 month | −3.4% |
| 3 months | −3.0% |
| 6 months | +11.7% |
| 1 year | +16.7% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 23.08 / 20.94 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Oct 2026 | USD 0.0925 |
| 6 Jul 2026 | USD 0.0820 |
| 7 Apr 2026 | USD 0.0820 |
| 6 Jan 2026 | USD 0.0806 |
| 6 Oct 2025 | USD 0.0800 |
| 3 Jul 2025 | USD 0.0775 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Thailand Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.